Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
03/2003
03/25/2003US6537751 Use determining genetic basis for disease states; identification of targets for development of drugs; diagnosis; Alzheimer's Disease
03/25/2003US6537749 Addressable protein arrays
03/25/2003US6537748 Reagent for nucleic acid typing by primer extension
03/25/2003US6537747 Data transmission using DNA oligomers
03/25/2003US6537746 Method for creating polynucleotide and polypeptide sequences
03/25/2003US6537744 Use of biomarkers in saliva to evaluate the toxicity of agents and the function of tissues in both biomedical and environmental applications
03/25/2003US6537570 Method of biological control
03/25/2003US6537560 Nucleic acid sequences encoding melanoma antigens recognized by T lymphocytes and protein and peptides encoded by these sequences
03/25/2003US6537523 Isolated macrophage having integrated into its genome a retroviral transcriptional controlling sequence positioned relative to a cell proliferation gene
03/25/2003US6537433 Integrated microfluidics
03/25/2003CA2399569A1 Diagnostic markers and drug targets for treatment of cancer
03/25/2003CA2382249A1 Microorganisms for use in the measurement of environmental factors
03/25/2003CA2274092C Gene-trapping construct for the identification and isolation of genes
03/25/2003CA2251262C Nucleic acid encoding a nervous tissue sodium channel
03/25/2003CA2224093C Human vascular endothelial growth factor 2
03/25/2003CA2201127C Genetic variety identifying method in hops
03/25/2003CA2173957C Novel trypanosoma cruzi antigen, and gene coding therefor; their application to the detection of chagas' disease
03/25/2003CA2123108C Human neuropeptide y-y1 receptor
03/25/2003CA2075182C Retinoid receptor compositions and methods
03/24/2003CA2357572A1 Method of diagnosis and disease risk assessment
03/20/2003WO2003023571A2 Methods for differential cell counts including related apparatus and software for performing same
03/20/2003WO2003023407A1 Methods of screening molecules that are used to prevent cardiovascular diseases
03/20/2003WO2003023405A1 Diagnostic and therapeutic use of f-box proteins for alzheimer's disease and related neurodegenerative disorders
03/20/2003WO2003023404A1 A method of diagnosis and treatment and agents useful for same
03/20/2003WO2003023399A1 Methods of detection of conformational change in a nucleic acid duplex by treatment with oxidising or reactive agent as a result of exposure to environmental or chemical conditions
03/20/2003WO2003023389A2 Solid electrochemical sensor
03/20/2003WO2003023380A1 Assay buffer, compositions containing the same, and methods of using the same
03/20/2003WO2003023366A2 Method and system for classifying a scenario
03/20/2003WO2003023365A2 Electrochemical sensor using intercalative, redox-active moieties
03/20/2003WO2003023363A2 Microcantilever apparatus and methods for detection of enzymes
03/20/2003WO2003023362A2 Methods of ameliorating arthritis by modulating jnk signalsome activity
03/20/2003WO2003023360A2 Methods and apparatus for conducting multiple measurements on a sample
03/20/2003WO2003023354A2 Optical bio-disc systems for nuclear morphology based identification
03/20/2003WO2003023353A2 Particle based homogeneous assays using capillary electrophoresis with laser-induced fluorescence detection
03/20/2003WO2003023066A1 Expression profiling in the intact human heart
03/20/2003WO2003023065A1 Dna methylation patterns
03/20/2003WO2003023063A1 Method of judging onset risk of diabetes
03/20/2003WO2003023062A2 Method of diagnosis for c.trachomatis infection using dna amplification assay on liquid cytology samples
03/20/2003WO2003023061A2 Reading, detection or quantification method, hybrids or complexes used in said method and the biochip using same
03/20/2003WO2003023060A2 Method and kit for diagnosing or controlling the treatment of breast cancer
03/20/2003WO2003023059A2 Method and kit for the diagnosis or treatment control of intestinal carcinoma
03/20/2003WO2003023058A2 Genetic analysis of biological samples in arrayed expanded representations of their nucleic acids
03/20/2003WO2003023057A2 Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
03/20/2003WO2003023056A2 Specific markers for multiple sclerosis
03/20/2003WO2003023055A2 Method for detecting mutations, insertions, deletions and polymorphisms on dna and the use thereof
03/20/2003WO2003023054A1 New assay for inhibitors of translocases
03/20/2003WO2003023053A2 Parameterization of absolute rate models for cytochrome p450 metabolism
03/20/2003WO2003023051A2 Lateral flow test format for enzyme assays
03/20/2003WO2003023048A2 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l)
03/20/2003WO2003023035A2 Glucosyltransferases which glucosylate abscisic acid
03/20/2003WO2003023031A1 Method of evaluating efficacy of nucleic acid therapy
03/20/2003WO2003023028A1 Fungal glyoxal oxidases
03/20/2003WO2003023014A2 Human ion channels
03/20/2003WO2003023013A2 Novel nucleic acids and polypeptides
03/20/2003WO2003023008A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
03/20/2003WO2003023001A2 Novel proteins and nucleic acids encoding same
03/20/2003WO2003022999A2 Rapid detection of replicating cells
03/20/2003WO2003022995A2 Nucleic acid and corresponding protein entitled steap-1 useful in treatment and detection of cancer
03/20/2003WO2003022993A2 Methods for producing ex vivo models for inflammatory disease and uses thereof
03/20/2003WO2003022989A2 Therapeutic agents that inhibit the tup1 pathway
03/20/2003WO2003022987A2 Methods of diagnosis of hepatitis c infection, compositions and methods of screening for modulators of hepatitis c infection
03/20/2003WO2003022986A2 Identification and quantification of nucleic acids by the production and serial sequencing of sequence tags having a uniform length
03/20/2003WO2003022882A2 Method of increasing the contractility of a heart, a heart muscle or cells of a heart muscle
03/20/2003WO2003022421A2 Microcolumn-platform based array for high-throughput analysis
03/20/2003WO2003022296A1 Method and composition for treating immune complex associated disorders
03/20/2003WO2003022123A2 Methods of kidney transplantation utilizing developing nephric tissue
03/20/2003WO2003022056A1 Use of acetohydroxy acid isomeroreductase inhibitors for treating fungal diseases affecting crops
03/20/2003WO2003022042A1 Enhanced resolution of tumor metastasis
03/20/2003WO2003022028A2 Methods, reagents, kits and apparatus for protein function analysis
03/20/2003WO2003004677A3 Methods for generating differential profiles by combining data obtained in separate measurements
03/20/2003WO2003000920A9 Methods for characterization of nucleic acid molecules
03/20/2003WO2003000848A3 Liver engrafting cells, assays, and uses thereof
03/20/2003WO2003000189A3 Prediction, diagnosis and treatment of endocrine resistant breast cancer, using p38 mapk pathway
03/20/2003WO2002101092A3 Oligonucleotides for detecting hybridisation
03/20/2003WO2002099075A3 Prmts as modifiers of the p53 pathway and methods of use
03/20/2003WO2002097135A9 Accurate and efficient quantification of dna sensitivity by real-time pcr
03/20/2003WO2002097113A3 Sequencing by proxy
03/20/2003WO2002088324A3 Methods for determining secondary modifications of molecules using arrays
03/20/2003WO2002086086A3 Methods to identify agents that bind the flap-tip helix of rna polymerase
03/20/2003WO2002085285A3 Methods and reagents for regulating bone and cartilage formation
03/20/2003WO2002084252A3 Epitope-captured antibody display
03/20/2003WO2002083927A3 Universal multi-variant detection system
03/20/2003WO2002079490A9 Bio-barcodes based on oligonucleotide-modified particles
03/20/2003WO2002079487A3 Methods, platforms and kits useful for identifying, isolating and utilizing nucleotide sequences which regulate gene expression in an organism
03/20/2003WO2002079404A3 Cytoskeleton-associated proteins
03/20/2003WO2002077290A9 Methods for modifying pharmacokinetics and bioavailability of exogenous compounds
03/20/2003WO2002077194A3 Polymer synthesis
03/20/2003WO2002073157A3 Direct detection of biomolecules in polyacrylamide gel
03/20/2003WO2002071929A3 Methods of decreasing non-specific binding in dual bead assays and system apparatus for detecting medical targets
03/20/2003WO2002071074A3 Method for analyzing proteins
03/20/2003WO2002069908A3 Methods for identifying compounds for regulating muscle mass or function using corticotropin releasing factor receptors
03/20/2003WO2002068603A9 Materials and methods for the induction of premature chromosome condensation
03/20/2003WO2002053733A3 Regulation of human b7-h2 protein
03/20/2003WO2002053728A3 Gene disruption methodologies for drug target discovery
03/20/2003WO2002053171A3 Use of intermediate-conductance potassium channels and modulators for the diagnosis and treatment of illnesses having disturbed keratinocyte activity
03/20/2003WO2002052269A3 Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases
03/20/2003WO2002052044A3 Detection of genetic polymorphisms in genes associated with pharmacogenomics
03/20/2003WO2002050255A3 Isolated human dehydrogenases, nucleic acid molecules encoding them, and uses thereof
03/20/2003WO2002050098A3 Haplotypes of the prlr gene
03/20/2003WO2002044405A3 Method and kit for the direct identification of nucleotide sequences, amino acid sequences or antigens